Palle Schelde Jensen

Plus aucun poste en cours

Health Technology

Commercial Services

Consumer Services

Profil

Palle Schelde Jensen formerly worked at LiPlasome Pharma A, as Chief Executive Officer, Anapa Biotech A, as Chief Executive Officer, Arcedi Biotech ApS, as Chief Executive Officer, Recepticon ApS, as Director, DNA Diagnostic A, as Director-Sales & Marketing, Proxeon Biosystems ApS, as Director, Fluxome Sciences A, as Director, FCMB ApS, as Director, Ranger Biotechnologies A, as Director, AH diagnostics A, as Sales Director, Inventure Capital A, as Partner from 2006 to 2010, Akzo Nobel A, as Product Manager, Organon A, as Principal, and Bayer A, as Product Manager.
Mr. Schelde Jensen received his graduate degree from the University of Aarhus.

Anciens postes connus de Palle Schelde Jensen

Sociétés	Poste	Fin
FCMB ApS FCMB ApS Miscellaneous Commercial ServicesCommercial Services Develops and provides non-invasive prenatal diagnostic technology	Directeur/Membre du Conseil	27/11/2013
Fluxome Sciences A/S Fluxome Sciences A/S BiotechnologyHealth Technology Provides biotechnology services	Directeur/Membre du Conseil	08/08/2013
Inventure Capital A/S Inventure Capital A/S Investment ManagersFinance Inventure's private equity investment strategy seeks to create value in early-stage Danish firms within selected sectors such as ICT (software and telecommunication), life science (pharmaceuticals, medical equipment and diagnostics) and industry (materials and energy). Their funds have a capital base of over €100 million. They seek syndication of investments with other Danish and international investors. They prefer to act as lead investor. As a minority shareholder, they provide primary funding by subscribing to new capital in portfolio firms. Key criteria for selecting new investment opportunities are solid management teams with proven industry experience, clear market demand for products, patented and scalable technology, and a strong partnership fit between Inventure and entrepreneurs, and a clear exit route. Inventure is an active investment partner. They contribute their industry expertise, take Board positions and work closely with the management team on strategy, funding, recruitment and exit planning.	Private Equity Investor	21/10/2010
Recepticon ApS Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage	Directeur/Membre du Conseil	23/03/2010
Arcedi Biotech ApS Arcedi Biotech ApS BiotechnologyHealth Technology Operates as biotechnology company, develops technologies for rare cell detection and cancer diagnostics	Directeur Général	-

Voir l'expérience en détail de Palle Schelde Jensen

Formation de Palle Schelde Jensen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Palle Schelde Jensen

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	15
University of Aarhus University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LiPlasome Pharma A/S LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, produces and supplies drugs for chemotherapy treatment	Health Technology
Inventure Capital A/S Inventure Capital A/S Investment ManagersFinance Inventure's private equity investment strategy seeks to create value in early-stage Danish firms within selected sectors such as ICT (software and telecommunication), life science (pharmaceuticals, medical equipment and diagnostics) and industry (materials and energy). Their funds have a capital base of over €100 million. They seek syndication of investments with other Danish and international investors. They prefer to act as lead investor. As a minority shareholder, they provide primary funding by subscribing to new capital in portfolio firms. Key criteria for selecting new investment opportunities are solid management teams with proven industry experience, clear market demand for products, patented and scalable technology, and a strong partnership fit between Inventure and entrepreneurs, and a clear exit route. Inventure is an active investment partner. They contribute their industry expertise, take Board positions and work closely with the management team on strategy, funding, recruitment and exit planning.	Finance
Recepticon ApS Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage	Health Technology
DNA Diagnostic A/S DNA Diagnostic A/S Pharmaceuticals: MajorHealth Technology Manufactures and supplies oligonucleotides	Health Technology
Proxeon Biosystems ApS Proxeon Biosystems ApS BiotechnologyHealth Technology Provides products and solutions for biotechnology research	Health Technology
Fluxome Sciences A/S Fluxome Sciences A/S BiotechnologyHealth Technology Provides biotechnology services	Health Technology
FCMB ApS FCMB ApS Miscellaneous Commercial ServicesCommercial Services Develops and provides non-invasive prenatal diagnostic technology	Commercial Services
Anapa Biotech A/S Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Provides molecular tools to enhance the performance of natural nucleic acids	Commercial Services
Akzo Nobel A/s
Organon A/S
Bayer A/S (Denmark) Bayer A/S (Denmark) Chemicals: Major DiversifiedProcess Industries Distributes chemical products	Process Industries
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Provides protein production technology	Commercial Services
AH diagnostics A/S AH diagnostics A/S Medical DistributorsDistribution Services Supplies products and services related to life science and diagnostics to pharmaceutical, biotech and hospitals	Distribution Services
Arcedi Biotech ApS Arcedi Biotech ApS BiotechnologyHealth Technology Operates as biotechnology company, develops technologies for rare cell detection and cancer diagnostics	Health Technology